Christian Kjellman
Keine laufenden Positionen mehr
Karriereverlauf von Christian Kjellman
Ehemalige bekannte Positionen von Christian Kjellman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HANSA BIOPHARMA AB | Geschäftsführer | 01.01.2008 | 01.02.2023 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | 01.02.2023 | |
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Cartela AB
 Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Christian Kjellman
| University of Lund | Graduate Degree |
Statistik
International
| Schweden | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Health Technology |
- Börse
- Insiders
- Christian Kjellman
- Erfahrung
